Arrhythmias & electrophysiology
Rationale and Design of the BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT (BACKBEAT) Pivotal Trial
Study context
- Population
- Patients implanted with, or scheduled to be implanted with, a dual-chamber pacemaker who have uncontrolled hypertension (office systolic blood pressure (oSBP) ≥135 mmHg and ambulatory systolic blood pressure (aSBP) ≥130 mmHg despite stable medical therapy)planned enrolment across up to 130 sites
- Participants
- ≈316 patients
- Planned comparison
- Atrioventricular interval modulation (AVIM) ON vs AVIM OFF
- Primary endpoint
- Between-group difference in the change of mean 24-hour aSBP from baseline
- Follow-up
- 3 months post-randomization
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Rationale and Design of the BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT (BACKBEAT) Pivotal Trial. Am Heart J. Published 11 November 2026. doi:10. 1016/ j. ahj. 2026. 107652
Composed by AI from the published abstract and checked against it. How Briefs are made →